Dechra overcomes major hurdle to US acquisition

INTERNATIONAL veterinary products company Dechra Pharmaceuticals has overcome a major hurdle in its plans to acquire a firm in the United States.

The listed Northwich, Cheshire company announced last month that it was prepared to pay £139m for pet remedy developer Putney, which is based in Portland, Maine.

Clearance for the deal to proceed has now come from the Department of Justice and the US Federal Trade Commission.

In a brief statement to the London Stock Market, Dechra said: “The mandato... You can carry on reading for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...